Dasatinib in Combination with BMS-754807 Induce Synergistic Cytotoxicity in Lung Cancer Cells through Inhibiting Lung Cancer Cell Growth, and Inducing Autophagy as Well as Cell Cycle Arrest at the G1 Phase
The authors demonstrated that dasatinib in combination with BMS-754807 inhibited lung cancer cell growth, while induced autophagy as well as cell cycle arrest at the G1 phase.